The application of complementary luminescent and fluorescent imaging techniques to visualize nuclear and cytoplasmic Ca2+-signalling during the in vivo differentiation of slow muscle cells in zebrafish embryos under normal and dystrophic conditions
- Authors
- Webb, S.E., Cheung, C.C., Chan, C.M., Love, D.R., and Miller, A.L.
- ID
- ZDB-PUB-110811-28
- Date
- 2012
- Source
- Clinical and experimental pharmacology & physiology 39(1): 78-86 (Journal)
- Registered Authors
- Love, Donald R., Miller, Andrew L., Webb, Sarah E.
- Keywords
- aequorin, Ca2+ signalling, dystrophin, sapje mutant, slow muscle cell, zebrafish
- MeSH Terms
-
- Animals
- Animals, Genetically Modified
- Calcium Signaling*/drug effects
- Cell Nucleus/drug effects
- Cell Nucleus/metabolism*
- Cell Nucleus/pathology
- Cytoplasm/drug effects
- Cytoplasm/metabolism*
- Cytoplasm/pathology
- Embryonic Development/drug effects
- Luminescent Measurements/methods
- Membrane Proteins/antagonists & inhibitors
- Membrane Proteins/genetics
- Membrane Proteins/metabolism
- Microscopy, Confocal
- Microscopy, Fluorescence/methods
- Morpholinos/pharmacology
- Muscle Contraction/drug effects
- Muscle Development*/drug effects
- Muscle Fibers, Slow-Twitch/drug effects
- Muscle Fibers, Slow-Twitch/metabolism*
- Muscle Fibers, Slow-Twitch/pathology*
- Muscle Proteins/antagonists & inhibitors
- Muscle Proteins/genetics
- Muscle Proteins/metabolism
- Muscular Dystrophies/embryology
- Muscular Dystrophies/metabolism*
- Muscular Dystrophies/pathology
- Mutation
- Organ Specificity
- Protein Transport/drug effects
- Sarcomeres/drug effects
- Sarcomeres/metabolism
- Sarcomeres/pathology
- Zebrafish
- Zebrafish Proteins/antagonists & inhibitors
- Zebrafish Proteins/genetics
- Zebrafish Proteins/metabolism
- PubMed
- 21824171 Full text @ Clin. Exp. Pharmacol. Physiol.
1. Evidence is accumulating for a role for Ca2+ signalling in the differentiation and development of embryonic skeletal muscle.
2. Imaging of intact, normally developing transgenic zebrafish that express the protein component of the Ca2+-sensitive complex, aequorin, specifically in skeletal muscle, show that two distinct periods of spontaneous synchronized Ca2+ transients occur in the trunk: at <17.5 hours post-fertilization (hpf)-19.5 hpf (termed signalling period, SP1); and after <23 hpf (termed SP2). These periods of intense Ca2+ signalling activity are separated by a quiet period.
3. Higher resolution confocal imaging of embryos loaded with the fluorescent Ca2+ reporter, calcium green-1 dextran, show that the Ca2+ signals are generated almost exclusively in the slow muscle cells, the first muscle cells to differentiate, with distinct nuclear and cytoplasmic components.
4. Here, we show that coincidental with the SP1 Ca2+ signals, dystrophin becomes localized to the vertical myoseptae of the myotome. Introduction of a dmd morpholino (dmd-MO) resulted in no dystrophin being expressed in the vertical myoseptae, as well as a disruption of myotome morphology and sarcomere organisation. In addition, the Ca2+ signalling signatures of dmd-MO-injected embryos or homozygous sapje mutant embryos were also abnormal such that the frequency, amplitude and timing of the Ca2+ signals were altered, when compared with controls.
5. Our new data suggest that in addition to a structural role, dystrophin may function in the regulation of [Ca2+]i during the early stages of slow muscle cell differentiation when the Ca2+ signals generated in these cells coincide with the first spontaneous contractions of the trunk.